• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普罗帕酮对人心房肌细胞复极电流的抑制作用。

Propafenone inhibition of human atrial myocyte repolarizing currents.

作者信息

Gross G J, Castle N A

机构信息

Department of Cardiology, Children's Hospital, Boston, MA 02115, USA.

出版信息

J Mol Cell Cardiol. 1998 Apr;30(4):783-93. doi: 10.1006/jmcc.1998.0643.

DOI:10.1006/jmcc.1998.0643
PMID:9602427
Abstract

This study was aimed at defining cellular electropharmacologic effects of propafenone on repolarizing currents in human atrial myocytes. Whole-cell patch-clamp of enzymatically isolated atrial myocytes from 11 cardiac surgical patients aged between 29 days and 74 years revealed potent time- and concentration-dependent (IC50 = 4.8 +/- 0.4 mumol/l), but age-, voltage-, and frequency-independent propafenone inhibition of transient outward current. Time course of apparent transient outward current inactivation was best described by a single exponential process in the absence of propafenone and by a double exponential model in its presence, with drug-concentration-dependent acceleration of the fast exponential component. Neither voltage dependence of steady-state transient outward current inactivation nor time course of recovery from inactivation was affected by propafenone. Significant inhibition (P < 0.05) of the ultra-rapidly activating delayed rectifier and inwardly rectifying currents was observed only in the presence of > or = 10 mumol/l propafenone. These actions of propafenone could explain its repolarization prolonging effect and might contribute to clinical electrophysiologic responses which have been documented in patients of all ages.

摘要

本研究旨在确定普罗帕酮对人心房肌细胞复极化电流的细胞电药理学效应。对11例年龄在29天至74岁之间的心脏手术患者经酶分离的心房肌细胞进行全细胞膜片钳研究,结果显示普罗帕酮对瞬时外向电流具有强大的时间和浓度依赖性(IC50 = 4.8 +/- 0.4 μmol/L)抑制作用,但与年龄、电压和频率无关。在不存在普罗帕酮时,表观瞬时外向电流失活的时间进程最好用单指数过程描述,而在其存在时则用双指数模型描述,快速指数成分的加速与药物浓度有关。普罗帕酮既不影响稳态瞬时外向电流失活的电压依赖性,也不影响失活后的恢复时间进程。仅在存在≥10 μmol/L普罗帕酮时,才观察到超快速激活延迟整流电流和内向整流电流受到显著抑制(P < 0.05)。普罗帕酮的这些作用可以解释其复极化延长效应,并可能有助于解释在各年龄段患者中记录到的临床电生理反应。

相似文献

1
Propafenone inhibition of human atrial myocyte repolarizing currents.普罗帕酮对人心房肌细胞复极电流的抑制作用。
J Mol Cell Cardiol. 1998 Apr;30(4):783-93. doi: 10.1006/jmcc.1998.0643.
2
Characterisation of transient outward current in young human atrial myocytes.年轻人类心房肌细胞瞬时外向电流的特性分析
Cardiovasc Res. 1995 Jan;29(1):112-7.
3
Potassium channel blocking properties of propafenone in rabbit atrial myocytes.普罗帕酮对兔心房肌细胞的钾通道阻滞特性
J Pharmacol Exp Ther. 1993 Mar;264(3):1113-23.
4
Alterations in outward K(+) currents on removal of external Ca(2+) in human atrial myocytes.去除细胞外钙离子后人心房肌细胞外向钾电流的变化
Biochem Biophys Res Commun. 2000 Jun 24;273(1):10-6. doi: 10.1006/bbrc.2000.2886.
5
Effects of propafenone on K currents in human atrial myocytes.普罗帕酮对人心房肌细胞钾电流的影响。
Br J Pharmacol. 1999 Mar;126(5):1153-62. doi: 10.1038/sj.bjp.0702428.
6
Flecainide inhibits the transient outward current in atrial myocytes isolated from the rabbit heart.氟卡尼抑制从兔心脏分离出的心房肌细胞中的瞬时外向电流。
J Pharmacol Exp Ther. 1995 Jul;274(1):315-21.
7
Transient outward current inhibition by propafenone and 5-hydroxypropafenone in cultured neonatal rat ventricular myocytes.
J Cardiovasc Pharmacol. 2001 Sep;38(3):460-7. doi: 10.1097/00005344-200109000-00014.
8
Propafenone and its metabolites preferentially inhibit IKr in rabbit ventricular myocytes.
J Pharmacol Exp Ther. 2004 Jan;308(1):59-65. doi: 10.1124/jpet.103.057844. Epub 2003 Oct 20.
9
L-type calcium current in pediatric and adult human atrial myocytes: evidence for developmental changes in channel inactivation.儿童和成人人类心房肌细胞中的L型钙电流:通道失活发育变化的证据。
Pediatr Res. 1996 Sep;40(3):462-8. doi: 10.1203/00006450-199609000-00016.
10
Histamine H1-receptor-mediated increase in the Ca2+ transient without a change in the Ca2+ current in electrically stimulated guinea-pig atrial myocytes.组胺H1受体介导的豚鼠心房肌细胞在电刺激下Ca2+瞬变增加而Ca2+电流无变化。
Br J Pharmacol. 1998 Aug;124(8):1744-50. doi: 10.1038/sj.bjp.0702008.

引用本文的文献

1
In Silico Assessment of Class I Antiarrhythmic Drug Effects on -Induced Atrial Fibrillation: Insights from Populations of Electrophysiological Models of Human Atrial Cells and Tissues.基于人群的人类心房细胞和组织的电生理模型探讨 I 类抗心律失常药物对 -诱导的心房颤动的作用的计算机评估。
Int J Mol Sci. 2021 Jan 27;22(3):1265. doi: 10.3390/ijms22031265.
2
Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome.与hERG相关的短QT综合征相关的人类心房病理电生理学药物治疗评估
Front Physiol. 2019 Jan 11;9:1888. doi: 10.3389/fphys.2018.01888. eCollection 2018.
3
Cardiovascular pharmacology of K17.1 (TASK-4, TALK-2) two-pore-domain K channels.
K17.1(TASK-4,TALK-2)双孔域钾通道的心血管药理学。
Naunyn Schmiedebergs Arch Pharmacol. 2018 Oct;391(10):1119-1131. doi: 10.1007/s00210-018-1535-z. Epub 2018 Jul 14.
4
Cardiac Potassium Channels: Physiological Insights for Targeted Therapy.心脏钾通道:靶向治疗的生理学见解
J Cardiovasc Pharmacol Ther. 2018 Mar;23(2):119-129. doi: 10.1177/1074248417729880. Epub 2017 Sep 25.
5
Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart.新型苄基呋喃喹啉血管舒张剂CIJ-3-2F在大鼠心脏中的机电及心房和心室抗心律失常作用
Br J Pharmacol. 2014 Aug;171(16):3918-37. doi: 10.1111/bph.12752.
6
Transient outward K+ current reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes.瞬时外向 K+ 电流减少可延长动作电位并促进后除极:人心房和兔心房间质细胞的动态钳研究。
J Physiol. 2012 Sep 1;590(17):4289-305. doi: 10.1113/jphysiol.2012.235986. Epub 2012 Jun 25.
7
Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.心房选择性钠通道阻滞策略抑制心房颤动:雷诺嗪与普罗帕酮。
J Pharmacol Exp Ther. 2012 Jan;340(1):161-8. doi: 10.1124/jpet.111.186395. Epub 2011 Oct 17.
8
[New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers].用于治疗心房颤动的新型抗心律失常药物:I. 离子通道阻滞剂
Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):64-72. doi: 10.1007/s00399-006-0512-2.
9
The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes.磺脲类药物格列本脲可抑制人心房和心室肌细胞的电压依赖性钾电流。
Br J Pharmacol. 1999 Nov;128(6):1175-80. doi: 10.1038/sj.bjp.0702904.